Oxford Biomedica plc (OXB) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Oxford Biomedica Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.798 And welcome to UXB 2025 preliminary results. 00:00:04.798 -- 00:00:09.525 We are joined today by Dr. Frank Mathias, Chief Executive Officer, Dr. 00:00:09.525 -- 00:00:12.690 Lucinda Crabtree, Chief Financial Officer, and Dr. 00:00:12.690 -- 00:00:15.935 Sebastian Brebold, Chief Business Officer. 00:00:15.935 -- 00:00:20.982 If you would like to ask a question during today's call, please press star 1 on your 00:00:20.982 -- 00:00:26.137 telephone keypad, or you can submit a written question via the toolbar below. 00:00:26.137 -- 00:00:28.942 I would now like to hand the call over to Dr. 00:00:28.942 -- 00:00:31.866 Frank Mathias. Please go ahead. 00:00:31.866 -- 00:00:36.974 Thank you so much for the introduction. Good morning to those in the US and good 00:00:36.974 -- 00:00:42.002 afternoon to everyone else and thank you for joining our OXB 00:00:42.002 -- 00:00:46.847 preliminary results briefing for the full year of 2025. 00:00:46.859 -- 00:00:52.408 Presenting alongside, as I just mentioned, with me today is our Chief Financial Officer, 00:00:52.408 -- 00:00:57.596 Dr. Lucy Crabtree, as well as our Chief Business Officer, Dr. 00:00:57.596 -- 00:00:59.596 Sebastian. 00:01:01.321 -- 00:01:03.385 Next slide, please. 00:01:03.385 -- 00:01:06.349 Before we begin, 00:01:06.349 -- 00:01:11.526 sorry, one back, yeah, sorry. Before we begin, I will quickly run through 00:01:11.526 -- 00:01:14.910 today's meeting agenda as seen now on the screen. 00:01:14.910 -- 00:01:20.617 We'll begin with a business update, providing an overview of OXP's key achievements 00:01:20.617 -- 00:01:25.723 over the period and highlighting the steps we have taken this year to further strengthen 00:01:25.723 -- 00:01:31.409 our position as a leading global cel...